Providing solutions for Antimicrobial Resistance and Viral Challenges

Disruptive Innovation.

Big pharma is struggling to innovate for many reasons, so it sources innovation from outside the sector—from biotech firms.

Innovation with a Practical Twist.

Viropin Pharmaceutical has a world-class, innovative, cross-disciplinary team focused on significant healthcare issues that are global in impact and scale. Their focus is on:

Solutions to overcome Antimicrobial Resistance (AMR) with a strong product pipeline utilizing novel and proprietary compounds.
- Hospital sterilants.
- Decolonization treatments.
- Pre-surgical scrubs.
- Woundcare solutions.
Anti-viral innovations (Influenza A & B) to mitigate the impact of future pandemics.

Viropin Pharmaceutical is operating under a disruptive pharma model to innovate and provide accelerated solutions to the market - for the betterment of humanity.

“The true sign of intelligence is not knowledge, but imagination.”

— Albert Einstein